Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Compensation-free dead cell exclusion: multi-beam excitation of the far-red DNA binding viability dye DRAQ7. (TECH2P.873)

Roy Edward and Ian Dimmick
J Immunol May 1, 2014, 192 (1 Supplement) 135.4;
Roy Edward
1BioStatus Limited, Shepshed, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian Dimmick
2Faculty of Medical Sciences, Newcastle University, Newcastle-upon-Tyne, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Reliable exclusion of dead/damaged cells is often needed for immunological assays by flow cytometry and cell sorting. DRAQ7 is a far-red biomarker of cell viability developed for this purpose. This water-soluble molecule binds dsDNA with high affinity but is membrane impermeant, only labeling cells with compromised membranes (Akagi, J. et al., 2013 and Smith, P.J. et al., 2013). Multi-colour analysis is limited by the available spectrum and preference for bright fluors, increasing compensation issues. DRAQ7 aids panel design by its emission: not overlapping Brilliant Violet dyes, FITC or R-PE and minimally with APC. Due to its specificity and affinity it provides clear s:n in membrane-compromised cells. DRAQ7 is optimally excited at 599 / 644 nm, however it is usefully excited down to blue wavelengths. In principle, this, so called, multi-beam excitation means DRAQ7 occupies multiple fluorescence channels. Conversely, this actually enables selection of a unique population of dead cells; plotting two independently excited far-red channels against each other one can choose a suitable pairing that gives the best separation of a double-positive population for a chromophore panel. This double-positive population is defined as a dead-cell gate of events then entirely excluded from other channels (avoiding any compensation). This can be achieved during acquisition or post-acquisition. The technical principles of this simple approach and exemplar data will be presented.

Previous
Back to top

In this issue

The Journal of Immunology
Vol. 192, Issue 1 Supplement
1 May 2014
  • Table of Contents
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Compensation-free dead cell exclusion: multi-beam excitation of the far-red DNA binding viability dye DRAQ7. (TECH2P.873)
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Compensation-free dead cell exclusion: multi-beam excitation of the far-red DNA binding viability dye DRAQ7. (TECH2P.873)
Roy Edward, Ian Dimmick
The Journal of Immunology May 1, 2014, 192 (1 Supplement) 135.4;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Compensation-free dead cell exclusion: multi-beam excitation of the far-red DNA binding viability dye DRAQ7. (TECH2P.873)
Roy Edward, Ian Dimmick
The Journal of Immunology May 1, 2014, 192 (1 Supplement) 135.4;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

  • A method for detecting protein expression in single cells using the C1™ Single-Cell Auto Prep System (TECH2P.874)
  • Direct isolation of untouched human neutrophils from whole blood in as little as 25 minutes (TECH2P.870)
  • Fully immunomagnetic isolation of untouched purified lymphocyte populations directly from whole blood without the need for red blood cell sedimentation, hypotonic lysis or density gradient centrifugation in just 25 minutes. (TECH2P.871)
Show more Late-breaking Technological Innovations in Immunology Session

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606